About Harleysville Medical Associates
Clinical Trials at Harleysville Medical Associates
During the past decade, Harleysville Medical Associates conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Harleysville Medical Associates" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Kowa Research Institute, Inc." with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Exact Sciences Corporation"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Harleysville Medical Associates"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Harleysville Medical Associates
According to Clinical.Site data, the most researched conditions in "Harleysville Medical Associates" are
"Diabetes Mellitus, Type 2" (3 trials), "Hyperlipidemia" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Atrial Fibrillation" (1 trials) and "Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)" (1 trials). Many other conditions were trialed in "Harleysville Medical Associates" in a lesser frequency.
Clinical Trials Intervention Types at Harleysville Medical Associates
Most popular intervention types in "Harleysville Medical Associates" are "Drug" (9 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "Bococizumab (PF-04950615; RN316)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Harleysville Medical Associates
The vast majority of trials in "Harleysville Medical Associates" are
12 trials for "All" genders.
Clinical Trials Status at Harleysville Medical Associates
Currently, there are NaN active trials in "Harleysville Medical Associates".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Harleysville Medical Associates,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Harleysville Medical Associates, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".